Also found in: Medical, Encyclopedia, Wikipedia.


n. hidradenitis, infl. de las glándulas sudoríparas.
References in periodicals archive ?
9, 2019 (HealthDay News) -- In a two-part guideline, published in the July issue of the Journal of the American Academy of Dermatology, the United States and Canadian Hidradenitis Suppurativa Foundations present recommendations for the diagnosis, evaluation, and management of hidradenitis suppurativa.
M2 PRESSWIRE-August 8, 2019-: Hidradenitis Suppurativa Pipeline Review, H1 2019 Report
'Rounding out the pipeline readout roster through the coming year, our clinical trials of avacopan in C3 glomerulopathy and hidradenitis suppurativa, along with our LUMINA 2 trial of CCX140 in patients with nephrotic proteinuria primary FSGS, are also enrolling well.
The purpose of this study is to investigate the safety and efficacy of IFX-1, a first-in-class anti-human complement factor C5a monoclonal antibody, in patients suffering from moderate to severe Hidradenitis Suppurativa (HS), a painful and debilitating chronic inflammatory skin disease with limited treatment options.
XBiotech announces that Alice Gottlieb M.D., Ph.D., will Chair the Companys upcoming Phase II study in Hidradenitis Suppurativa (HS).
Ongoing trials include: two Phase 3 programmes evaluating guselkumab in the treatment of active PsA and a Phase 2b programmes in Crohn's disease, and two Phase 2 programmes one for the treatment of ulcerative colitis and the other for the treatment of hidradenitis suppurativa.
In the case of pediatric hidradenitis suppurativa, the disease itself may be hidden from view by reticent teens; once diagnosed, providers must remain vigilant for occult associations including precocious puberty and polycystic ovarian syndrome.
The author of this report has worked with 47 patients with hidradenitis suppurativa who followed his recommendation to eliminate dairy products from their diet.
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease, characterized by the presence of painful nodules and abscesses in apocrine gland-bearing areas (1-3).
announced that they have received approval for an additional indication of HUMIRA (generic name: adalimumab [recombinant], "HUMIRA"), a fully human anti-TNF-alpha monoclonal antibody, for the treatment of hidradenitis suppurativa (HS).
The symposium will include speakers and a presentation on hidradenitis suppurativa, a chronic skin disease with a higher prevalence in patients with skin of color, particularly African-Americans and Hispanics.
Hidradenitis suppurativa (HS) is a chronic disease with frequent recurrences.